Cusa Clarity
Payments companies reported to CMS as associated with Cusa Clarity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cusa Clarity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cusa Clarity
These are the largest totals companies reported as associated with Cusa Clarity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adnan Alseidi | Seattle, WA | Surgery | $10,615.00 |
| Lynn Kowalski | Las Vegas, NV | Gynecologic Oncology | $9,450.00 |
| Lawrence Dickinson | Castro Valley, CA | Neurological Surgery | $7,250.00 |
| Gerald Grant | Stanford, CA | Neurological Surgery | $4,925.10 |
| Michael Kim | Orange, CA | Neurological Surgery | $2,839.63 |
| Azadeh Farin | Long Beach, CA | Neurological Surgery | $2,080.51 |
| De Ette Vasques | Fort Worth, TX | Gynecologic Oncology | $1,924.85 |
| Matthew Tormenti | Freehold, NJ | Neurological Surgery | $1,754.60 |
| Ramin Javahery | Long Beach, CA | Neurological Surgery | $1,724.99 |
| Aditya Iyer | Mission Hills, CA | Neurological Surgery | $1,476.65 |
Prescribed Cusa Clarity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.